Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ronald Koff

Family Medicine New Castle, KY Medical Doctor

NPI 1326136789 CMS profile 151226

15 So Main St, New Castle, KY 40050

Open in the dashboard

General payments

$70,902

828 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,794 paid to institutions, not to them · program years 2020–2024

Through program year 2025, Ronald Koff of New Castle, KY is reported in the CMS Open Payments database as having received $70,902 across 828 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,794 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,100 11
2024 General $2,057 19
2023 General $3,038 52
2022 General $17,172 215
2021 General $19,997 252
2020 General $3,104 122
2019 General $24,434 157

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ronald Koff
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Ronald Koff were reported at $1,100. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Ronald Koff Family Medicine median Middle half National median
2019 $24,434 $150 $41–$543 $163
2020 $3,104 $120 $32–$415 $114
2021 $19,997 $137 $35–$551 $132
2022 $17,172 $137 $37–$512 $149
2023 $3,038 $149 $42–$545 $160
2024 $2,057 $156 $44–$560 $164
2025 $1,100 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Esperion Therapeutics, Inc. $24,896 137 payments
  2. Janssen Pharmaceuticals, Inc $21,278 71 payments
  3. Novo Nordisk Inc $4,027 73 payments
  4. AstraZeneca Pharmaceuticals LP $3,108 60 payments
  5. GlaxoSmithKline, LLC. $1,769 47 payments
  6. Amgen Inc. $1,684 55 payments
  7. Novartis Pharmaceuticals Corporation $1,588 38 payments
  8. AbbVie, Inc. $1,370 62 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $1,163 37 payments
  10. Otsuka America Pharmaceutical, Inc. $818 27 payments
  11. Other $9,201 221 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $39,768 30 payments
  2. Food and Beverage $26,365 761 payments
  3. Travel and Lodging $2,719 33 payments
  4. Consulting Fee $2,040 2 payments
  5. Education $9 2 payments
Products named General payments · program years 2019–2025
  1. NEXLETOL $24,896 137 payments
  2. NEXLIZET $24,318 69 payments
  3. INVOKANA $20,225 45 payments
  4. RYBELSUS $2,745 38 payments
  5. FARXIGA $1,433 29 payments
  6. XARELTO $1,345 41 payments
  7. Ozempic $983 40 payments
  8. TRELEGY ELLIPTA $892 31 payments
  9. Repatha $847 42 payments
  10. REXULTI $818 27 payments
  11. Other $18,689 556 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

828 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record